Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
MS in tijden van COVID-19
mei 2021 | Multipele Sclerose, Vaccinatie, Virale infecties